Companion Diagnostics Market Size is estimated to grow at a CAGR of 20.0% during the forecast period
Over the forecast period of 2022–2030, the global companion diagnostics market is
expected to develop at a CAGR of 20.0%.
A companion diagnostic is an in vitro medical tool that is
used in conjunction with a therapeutic medication to assess the efficacy and
suitability of the medication for individual patients. In order to give safe
and effective medical treatment, it makes use of a combination of tests and
therapies to provide vital information on related medicinal pharmaceuticals or
biological products. In-depth knowledge of disease biology and the mechanism of
action (MOA) is also provided by these diagnostics, which helps medical
practitioners assess the dangers or adverse effects of a therapeutic product on
particular human bodies.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/companion-diagnostics-market
GROWTH DRIVERS:
The global companion diagnostics market is primarily driven
by factors like the growing number of clinical trials, the growing development
of new biomarkers for various diseases, the blossoming cases of adverse drug
reactions related to drugs due to lack of efficacy, the rapidly increasing
number of technological advancements in healthcare, and the ever-expanding
application areas of companion diagnostics due to a variety of advantages
offered by them. It is also driven by the growing significance of companion
diagnostics in drug development.
Additionally, a number of other factors, including the
growing importance and demand for personalized medicine, the number of unmet
needs for cancer treatment, the aging population's growing critical healthcare
needs, improvements in regulatory guidelines, the increasing emphasis on the
co-development of drugs and diagnostic technologies, the rapid growth of
genomics and proteomics research, and the growing number of government-based
initiatives and spending, are anticipated to further support the growth of the
global companion diagnostics market over
the course of the forecast period.
COMPANION DIAGNOSTICS MARKET SEGMENTATION:
By Product & Services:
· Assay
Kits & Reagents
· Software
& Services
By Technology:
· Polymerase
Chain Reaction (PCR)
· In
Situ Hybridization (ISH)
· Next-Generation
Sequencing (NGS)
· Immunohistochemistry
(IHC)
· Others
By Indication:
· Cardiovascular
· Neurological
Diseases
· Cancer
o Breast
Cancer
o Lung Cancer
o Colorectal
Cancer
o Melanoma
o Gastric
Cancer
o Infectious
Diseases
o Others
By End User:
· Pharmaceutical
& Biopharmaceutical Companies
· Reference
Laboratories
· Contract
Research Organizations
· Others
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
KEY COMPANIES IN COMPANION DIAGNOSTICS MARKET:
· Hoffmann-La
Roche AG
· Agilent
Technologies Inc.
· Biogenex
Laboratories Inc.
· Abbott
Laboratories Molecular Inc.
· ARUP
Laboratories Inc.
· BioMerieux
SA
· Danaher
Corporation
· Foundation
Medicine Inc.
· Almac
Group
· Sysmex
Corporation
· Thermo
Fisher Scientific Inc.
· Abnova
Corporation
· Guardant
Health Inc.
· Icon
Plc
· Myriad
Genetics Inc.
· Qiagen
N.V.
For
More Information about this Report @ https://www.xresearch.biz/shop/companion-diagnostics-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment